3 days How A Side Effect Has Wiped Out 73% Of Neurogene’s Value In A WeekInvestor's Business Daily
Neurogene stock collapsed, again, on Monday after the company scrapped the high dose of its experimental Rett Syndrome treatment.
The post How A Side Effect Has Wiped Out 73% Of Neurogene's Value In A Week appeared first on Investor's Busines…